| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
ABSTRACT |
|---|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The role of small airways in the immediate allergic response is largely unknown. We therefore used the model of precision-cut lung slices (PCLS) in combination with quantitative videomicroscopy to study the early allergic response to allergen in airways ranging from 50 to 900 µm. After PCLS from untreated Wistar rats had been passively sensitized for 16 h with serum from sensitized Brown Norway rats, exposure to 0.1% ovalbumin resulted in an immediate allergic response. Both extent (r = 0.74, p < 0.0001) and velocity (r = 0.49, p < 0.0001) of the allergen-induced bronchoconstriction increased with decreasing airway size. In addition, we observed that smaller airways not only contracted stronger and quicker, but that they also relaxed faster, suggesting that smaller airways are more reactive in principle. The allergen-induced bronchoconstriction in PCLS was prevented by the serotonin receptor antagonist ketanserin (IC50 6 nM), but not by antagonists directed against histamine, acetylcholine, PAF, or endothelin receptors, or by cyclooxygenase or lipoxygenase inhibitors. Like allergen, serotonin provoked responses that were stronger in smaller airways. These findings suggest that the immediate allergic response in rat PCLS depends largely on serotonin and that this response can occur in nearly all airway generations, but is most pronounced in the smallest airways, that is, the terminal bronchioles.
| |
INTRODUCTION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Asthma is an inflammatory disease process that affects the whole airway tree from large to small (< 2 mm) airways (1). Up to now, however, the focus has been on the large airways and the small airways have been, not the least because of technical problems, mostly ignored. The current knowledge of the role of small airways in asthma has been reviewed (1, 2). The authors agreed that asthma occurs also in the small airways, but it became clear that the evidence therefore is incomplete and that the contribution of the small airways to asthma remains to be clarified. The present evidence of a role of small airways in asthma is based mainly on three types of observations. First, histological examination of airways from patients with asthma showed that both the inflammation as well as the airway remodeling in these lungs are not confined to airways of any particular size, but occur throughout the entire bronchial tree (3). Second, it is supposedly this inflammation with the structural changes that it produces in the small airways that leads to a 7-fold increase in peripheral lung resistance in subjects with asthma compared with control subjects (4). A comparable increase in peripheral airway resistance in patients with asthma was also confirmed by others (5). Third, there is evidence of a role of increased responsiveness of small airways in asthma. Peripheral airways of patients with asthma but not of control subjects constricted in response to dry air (6) and bradykinin (7). It was also shown that peripheral airways of asthmatics responded more strongly to histamine (8). And finally, in passively sensitized human bronchi of different sizes it was shown that smaller airways responded more strongly to antigen. (9). These authors examined airways down to a diameter of 0.5 mm; their method did not allow them to study smaller airways. Thus, there is as yet only limited direct evidence that small airways can contract in response to allergen and, if so, down to which airway size or airway generation this occurs.
We have developed a method that allows examination of this question, namely the video microscopy of precision-cut lung slices (10). With this method airways are cut into thin (220-µm) viable lung slices that are taken into culture. Constriction of airways is observed under a microscope, which in combination with video microscopy and digital imaging techniques makes it possible to visualize and quantify bronchoconstriction. The smallest airways that we have been able to analyze by this technique have a diameter of only 50 µm, corresponding roughly to the terminal bronchioles (11). In humans, airways with a diameter smaller than 2 mm have been termed small airways (12), that is, airway generation 11 in humans. The corresponding airway generation in rats has a diameter of 780 µm (13), and terminal bronchioles, which start at generation 16, have a corresponding diameter of 200 µm (13). However, such comparisons should be made cautiously, because it is not completely clear how to compare airway size between humans and rats.
To study the response of precision-cut lung slices to allergen, the slices were passively sensitized. Naive cells or tissue can be made sensitive to allergen by incubating them with serum from an allergic subject (animal or human), a process that is referred to as passive sensitization. In the in vitro passive sensitization model, IgE accounts for specific, but not for nonspecific, responses (14).
It was the aim of this study to investigate the immediate allergic response in small airways down to the terminal bronchioles. Therefore, we have examined the effect of passive sensitization and subsequent exposure to the specific antigen ovalbumin on airways < 0.9 mm in diameter. Because our results showed that an immediate allergic response takes place in small airways, we used various inhibitors to investigate the underlying mechanism of antigen-induced bronchoconstriction in small airways.
| |
METHODS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Animals
Lungs were taken from 8-wk-old female Wistar rats (220 ± 20 g) obtained from Harlan Winkelman (Borchen, Germany) and kept under controlled conditions (22° C, 55% humidity, 12-h day/night rhythm) on a standard laboratory chow.
Chemicals
Ovalbumin (Grade V), methacholine, indomethacin, cromolyn, ketanserin, and tripolidine were purchased from Sigma (Deisenhofen, Germany). AA861 was purchased from Biomol (Hamburg, Germany). WEB 2086 was a personal gift from H. O. Heuer (Boehringer Mannheim, Mannheim, Germany). Bosentan was a kind gift from H. Clozel (Actelion, Allschwil, Switzerland).
Serum
Serum was a generous gift from D. Marx and W. Poppe (Arzneimittelwerke Dresden, Dresden, Germany). Serum was obtained from male Brown Norway rats (200 g) sensitized to ovalbumin or from control animals. Rats were actively sensitized by subcutaneous injections of a suspension of 10 µg of ovalbumin Grade VI (OVA) plus 20 mg of Al(OH)3 gel and intraperitoneal Bordetella pertussis vaccine (about 400 × 106 heat-inactivated bacteria) on Days 1, 14, and 21. On Day 28 the animals were exposed to a nebulized aerosol of ovalbumin solution (10 mg of ovalbumin/ml) in a nose-only inhalation system for 60 min. Vehicle-treated control animals were exposed to a saline aerosol. The aerosol was generated by a nebulizer driven by compressed air at 0.2 MPa. Forty-eight hours later, animals were killed by urethane overdose (1.5 g/kg body weight, intraperitoneal) and blood was sampled from their hearts.
Serum samples were pooled (n = 5) and the IgE concentration was determined by enzyme-linked immunosorbent assay (ELISA). Total IgE concentration in serum from sensitized rats varied between 800 and 1000 IU/ml. Total IgE levels in control serum were below the detection level.
Precision-cut Lung Slices
Precision-cut lung slices (PCLS) were prepared from isolated perfused lungs (15, 16) and treated and analyzed as previously described for rat (10) and mouse (17) tissue. Briefly, rat lungs were dissected from the animal and perfused blood free with Krebs-Henseleit buffer supplemented with 0.1% glucose and 0.3% HEPES. Subsequently, the lungs were filled with agarose solution (0.75%) via the trachea and put on ice to allow the agarose to cool and solidify. The lung lobes were separated and cut into 5- to 10 mm-thick slabs from which cores along the airways were made with a coring tool. These cores were cut into 200 ± 20 µm-thick slices with the help of a Krumdieck tissue slicer (Alabama Research and Development, Munford, AL). Slices were incubated in minimal essential medium (MEM) and medium was changed every half hour for the first 2 h and then every hour for the next 2 h to remove the agarose from the airways. For analysis, lung slices were moved into a prewarmed 24-well plate. The airways were imaged and digitized with a digital video camera (Visitron 1300; Visitron Systems, Munich, Germany) controlled by the image analysis software Metamorph (Universal Imaging, West Chester, PA). One image of 2.28 mm2 was represented by 1,280 × 1,024 pixels. The images were analyzed by the image analysis program Optimas 6.2 (Optimas, Bothell, WA). The lumenal area was taken as the area enclosed by the epithelial border and was quantified after setting the appropriate threshold (a setting in digital imaging software that allows definition of the foreground of the image by selecting a range of gray values). Airway area before addition of the antigen was defined as 100%. Bronchoconstriction was expressed as the percentage decrease in airway area in comparison with the control airway area.
Passive Sensitization
Incubation medium containing penicillin and streptomycin for overnight incubation was supplemented with 1% serum from either sensitized or control rats. Alternatively, serum from sensitized animals was incubated at 60° C for 60 min to inactivate IgE. PCLS were then incubated, each with 1 ml of serum-containing MEM. PCLS were incubated at 37° C and 5% CO2 in an incubator overnight (approximately 15 h). The next day, the PCLS received fresh medium free of antibiotics. They were kept in an incubator until needed.
Inhibition Experiments
To investigate the mechanism that underlies the immediate allergic response we preincubated PCLS with various inhibitors before challenge with the antigen ovalbumin. In all cases the preincubation time was 10 min.
Statistics
Data are expressed as means ± standard deviation (SD). Data were
examined by analyzing the maximum values (Figures 1-4 and 8) or
the area under the curve (AUC; Figures 6, 7, and 9) by two-sided t
tests. Homoscedasticity was confirmed by F test. In case of heteroscedasticity data were log transformed. The 
error resulting from multiple comparisons was adjusted by the method of Hommel (18). p < 0.05 was considered significant.
|
|
|
|
|
|
|
8.235 ± 0.266. Data represent means ± SD of five independent experiments at each ketanserin concentration. The mean airway areas were not different from each other, i.e., 1 nM ketanserin,
338,302 ± 129,473 µm2; 10 nM, 434,160 ± 144,681 µm2; 100 nM,
427,794 ± 106,983; 1 µM 418,766 ± 62,382 µm2.
|
| |
RESULTS |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
Passive Sensitization of Precision-cut Lung Slices
To see whether an immediate allergic response can principally be induced in precision-cut rat lung slices, slices were incubated (passively sensitized) with 1% serum from Brown Norway rats sensitized against ovalbumin for 4 h and subsequently exposed to 0.1% ovalbumin (Figure 1). Figure 1 shows that after adding the antigen, airways showed a rapid contraction within 2 min that was partially reversible within the next 8 min. The response to allergen was not repeatable, that is, no response occurred if passively sensitized and subsequently challenged lung slices, whose airway calibers had returned to baseline, were exposed to ovalbumin a second time (data not shown).
We next investigated how long slices had to be passively sensitized before addition of ovalbumin elicited bronchoconstriction. Cell culture medium containing 1% serum from rats sensitized to ovalbumin was transferred onto lung slices. One, 2, 3, 4, or 16 h after serum transfer the lung slices were challenged with 0.1% ovalbumin and the reaction was monitored for 10 min. Figure 2 demonstrates that slices had to be passively sensitized for at least 2 h, before they responded to the antigen; the maximum response to ovalbumin, however, did not occur before 4 h. These observations led to the decision to incubate the lung slices overnight with serum before carrying out the antigen exposure in the following experiments. We also investigated the influence of various concentrations of the specific antigen ovalbumin on airway contraction in passively sensitized rat lung slices. At concentrations lower than 0.1% ovalbumin airways showed a weaker and more inconsistent contraction (data not shown). We therefore chose an ovalbumin concentration of 0.1% for the following experiments.
In lung slices incubated with either control serum from nonsensitized rats or heat-inactivated serum (60° C for 1 h) from sensitized rats, ovalbumin did not cause bronchoconstriction. Also, overnight sensitization with 1% serum from sensitized rats and subsequent challenge with a nonspecific antigen (Phleum pratense pollen extract) did not cause bronchoconstriction (Table 1).
|
Airway Size Dependence of the Immediate Allergic Response
Whether small airways contribute to the pathophysiology of asthma is an important unsolved question. Therefore we examined the dependence of antigen-induced bronchoconstriction in passively sensitized lung slices on airway size. We investigated airways ranging from 10,000 to 650,000 µm2 (corresponding to a diameter of 110-910 µm). These airways were sensitized overnight with 1% serum and subsequently challenged with 0.1% ovalbumin. Bronchoconstriction was then assessed for 10 min. Figure 3 shows a scatter diagram of airway size plotted against the maximum degree of airway contraction within this time period. We found a highly significant correlation between airway size and contraction (r = 0.74; p < 0.0001). Forty-two out of 52 airways (80.8%) smaller than 100,000 µm2 exhibited complete bronchoconstriction, whereas only 11 airways of 58 (19%) with a size above 100,000 µm2 closed completely (p < 0.001, Fisher exact test). We found that smaller airways not only reacted stronger, but also faster. Figure 4A shows a correlation diagram of airway size plotted against the time that was required to reach maximum contraction in that slice (not necessarily complete closure of airway). Forty-three out of 52 (82.7%) airways < 100,000 µm2 reached maximum contraction 2 min after adding 0.1% ovalbumin compared with only 32 of 58 (55.2%) in airways with an area larger than 100,000 µm2 (p = 0.0022, Fisher exact test). Thus, antigen-induced bronchoconstriction depends on airway size such that the smaller the airways the stronger and quicker the response to specific antigen. Finally, we also found a significant correlation between the time required to reach maximum contraction and the degree of contraction of the individual airways. Airways that reacted rapidly after challenge with ovalbumin also reacted stronger than airways with a slower reaction time (Figure 4B).
The fact that smaller airways contracted to a greater extent and also faster than larger airways, might be explained if large airways were relaxing quicker than smaller airways. However, Figure 5 shows that the opposite was the case, that is, smaller airways not only contracted faster, but they also relaxed faster than larger airways.
|
We also sensitized slices containing very small, very distal airways with an area less than 10,000 µm2. These airways lacked a distinct muscle layer and were identified as airways by looking at the ciliary lining on the epithelium. Even these very small airways elicited a reaction when challenged with specific antigen. However, as Figure 6 illustrates these airways responded heterogeneously. Because airways of this size are difficult to obtain, we did not further investigate these extremely small airways.
Mechanism of the Immediate Allergic Response in Lung Slices
To investigate the mechanism of ovalbumin-induced bronchoconstriction in lung slices, we preincubated rat PCLS with a variety of inhibitors before exposing them to specific antigen. Table 2 (19) summarizes the data obtained from these experiments. Because it is well known that stimulation with antigen leads to mast cell degranulation (which is also supported by the fact that the effect of ovalbumin was not repeatable as noted above), we tested whether prestored mediators such as histamine or serotonin play a role in antigen-induced bronchoconstriction. We used the histamine H1 receptor antagonist tripolidine and the serotonin (5-hydroxy-tryptamine, 5-HT) receptor antagonist ketanserin. Whereas preincubation with tripolidine did not prevent bronchoconstriction, ketanserin completely inhibited the ovalbumin-induced bronchoconstriction. A dose-response curve was established for ketanserin to determine the median inhibitory concentration (IC50) in our system. The IC50 value was 5.8 nM (Figure 7). To test whether the released serotonin directly activated airway smooth muscle cells or whether it bound to postganglionic synapses leading to an increased release of acetylcholine, we used atropine to block muscarinic receptors. At a concentration of 100 nM, atropine had only a small effect on ovalbumin-induced bronchoconstriction, indicating that serotonin binds to receptors directly on the airway smooth muscle cells, rather than exhibiting a secondary effect by inducing release of bronchoconstrictory neurotransmitters from nerve endings (Table 2).
|
Inhibition of leukotriene synthesis with the 5-lipoxygenase inhibitor AA861 or of prostaglandin synthesis with the cyclooxygenase inhibitor indomethacin had no effect on ovalbumin-induced bronchoconstriction (Table 2). Also, blockade of platelet-activated factor (PAF) receptors with WEB 2086 or of endothelin receptors with bosentan failed to prevent the immediate allergic response. Finally, preincubation with cromolyn, an agent that is also used in asthma therapy, failed to block the ovalbumin-induced bronchoconstriction.
These findings indicated that the major mediator responsible for the antigen-induced bronchoconstriction in our model
was serotonin. We therefore investigated whether serotonin,
like allergen, also contracted smaller airways to a greater degree than larger airways. Serotonin contracted control airways
in the same manner (i.e., with a similar time course) as ovalbumin contracted sensitized airways (data not shown). As shown
in Figure 8, we observed a similar, significant correlation between airway size and maximum contraction in response to serotonin (10
5 M).
Effect of Hydrocortisone
In additional experiments, the incubation medium was supplemented with hydrocortisone (HC, 0.1 µg/ml) and subsequently several precision-cut lung slices were incubated overnight with 1% serum from sensitized rats along with HC. The next day, slices were challenged with 0.1% ovalbumin and contraction was compared with that of lung slices sensitized and incubated in MEM free of HC. We found that maximum contractility was diminished in precision-cut lung slices that were preincubated in HC-containing medium (Figure 9). Maximum contractility was 94.9% without HC versus 71.4% for slices treated with HC.
| |
DISCUSSION |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
The present study provides direct evidence that immediate allergic reactions can occur in small airways down to the terminal bronchioles. There appears to be no principal difference in the allergic responses of differently sized airways. Of note, the sensitivity to allergen increased along the bronchial tree such that terminal bronchioles were more sensitive to allergen than larger airways. Our pharmacological studies further suggest that serotonin is the major mediator responsible for the allergen-induced bronchoconstriction in rats. In line with this, smaller airways were more sensitive to both allergen and serotonin. These findings suggest that the increased sensitivity of smaller airways to allergen is at least partly explained by an increased sensitivity toward serotonin.
Model of Precision-cut Lung Slices
PCLS offer a novel way to study the functional responses of small airways under cell culture conditions. Using various criteria (lactate dehydrogenase [LDH] release, mitochondrial activity, thymidine incorporation, responsiveness to methacholine), we previously have shown that PCLS are viable for at least 1 d under standard cell culture conditions, and for at least 3 d if they are maintained in a dynamic organ culture (10). Investigations of intrinsic tone showed that it is absent in rat PCLS (10).
In a subsequent study using murine tissue, it was demonstrated that the responsiveness of PCLS to a variety of different agonists is qualitatively and quantitatively similar to responses in the whole organ (17). Thus, PCLS have been established as a reliable tool with which to study small airway responses.
It should be noted, however, that it appears mandatory to use thin slices of reproducible thickness. This is illustrated if experiments with PCLS are compared with those with razor-cut lung slices. Whereas PCLS show highly reproducible responses to methacholine, comparable to those seen in other models such as tracheal rings or isolated lungs, the responses observed in razor-cut lung slices vary to a degree that largely precludes their use in functional studies. For example, the EC50 values for methacholine-induced bronchoconstriction vary 5,000-fold in PCLS (only 200-fold if stratified for airway size) (10), but 550,000-fold in razor-cut lung slices (27). The reasons for these differences have been discussed previously (10).
Dandurand and coworkers (28) were the first to study allergic bronchoconstriction in vitro in lung explants prepared from ovalbumin-sensitized Brown Norway rats, although they did not investigate different airway sizes. They used lung slices with a thickness between 0.5 and 1.0 mm, challenged with 10% ovalbumin, and imaged the responses for 10 min. They observed an immediate allergic response in almost all lung explants derived from sensitized animals. The maximal response for sensitized airways was 42 ± 24% versus 4 ± 3% for lung slices from control animals and peaked within 1-8 min. Compared with these findings, passively sensitized precision-cut lung slices reacted more strongly (78.5%), despite a 100-fold reduced ovalbumin concentration. Besides technical issues, the comparatively small reactivity observed by Dandurand and coworkers might also be explained by the presence of hydrocortisone (0.1 µg/ml) in their incubation medium. We found that exposure to hydrocortisone decreased the maximum contractility of airways after challenge with the antigen ovalbumin (Figure 9). Another notable difference between their study and ours is that they used explants from sensitized rats, whereas we used passive sensitization.
It might be assumed that the enhanced responsiveness of smaller airways to allergen is an inherent property of the slice model, because smaller airways are also more sensitive toward both methacholine (10) and thromboxane (29). Therefore it is important to point out the fact that small and large airways react almost equally strong to endothelin 1 (29). That the relative sensitivity of small and large airways in PCLS differs from agonist to agonist indicates that biological mechanisms rather than model properties are responsible for this behavior. Thus the increased sensitivity of smaller airways to allergen is most likely explained by either enhanced production of serotonin and other mediators or by a greater reactivity of the smaller airways to these mediators (see below).
Serotonin Mediates Allergen-induced Bronchoconstriction in PCLS
It is well known that the major mediator in allergic bronchoconstriction in rats is serotonin (30). The present study confirms these findings and extends them to the small airways. In keeping with this, Purcell and coworkers (31) have shown that pulmonary mast cells (which are the most likely source of serotonin in our model) contain biogenic amine at approximately 25 pg/cell, of which more than 80% is serotonin.
Martin and colleagues (32, 33) have shown that in addition to serotonin, leukotriene D4 may also contribute to the early response in rats. However, in our model lipoxygenase inhibition was not effective and thus in rat PCLS serotonin appears to be the sole mediator of antigen-induced bronchoconstriction. Nagase and coworkers (34) investigated the role of serotonin and leukotriene D4 (LTD4) in central airways and in parenchymal tissue in sensitized rats. Whereas in their system the bronchial response was completely abolished by serotonin receptor antagonism (as in our system), the parenchymal strip response was only partially affected and the authors showed that in parenchymal tissue LTD4 is involved in the anaphylactic response. However, the parenchymal strip is made up of a number of different anatomic structures, including small airways, small vessels, and alveolar walls. Therefore, contractile responses of parenchymal strips are likely to reflect a complex interplay among these various elements. Hence, parenchymal strips have some limitations in studying the role of small airways in anaphylactic bronchoconstriction.
The above-described findings suggest that serotonin is the major mediator of allergen-induced bronchoconstriction in rats. In addition, we observed that serotonin, like allergen, preferentially contracted small airways. Unfortunately, not much is known about the distribution of serotonin receptors along the bronchial tree. Das and Steinberg (35) identified several serotonin-binding receptors in the rat lung. However, their analysis of extracted lung tissue revealed only a general localization of serotonin receptors on microsomal and mitochondrial membrane fractions. Serotonin receptors have been attributed to epithelial cells, neurons, and smooth muscle cells. Although the distribution of serotonin receptors in the airways is unknown, examples of such heterogeneity are given by vasoactive intestinal peptide (VIP) receptors that prevail in proximal airways, in contrast to tachykinin receptors, which are more prominent in distal airways (36). Bradley and Russell (40) investigated the distribution of histamine receptors in isolated canine airways of different size. They observed that responses to histamine were more pronounced in intrapulmonary airways than in tracheal strips and concluded that histamine sensitivity in canine airways varies within the bronchial tree. In line with this Wagner and colleagues observed that even in healthy humans small airways were "surprisingly responsive" to histamine (8). All these examples lend support to the hypothesis that serotonin receptors might also be distributed heterogeneously along the airways.
Airway Size and Immediate Allergic Responses
Previously the small airways have been dubbed the silent zone. Only a few previous studies have examined early allergic airway responses as a function of airway size (9, 34, 41). Among these studies, this is the first in which airways smaller than 500 µm in diameter including terminal bronchioles have been investigated. The relationship between airway size and airway generation in rat lungs is indicated in Figure 3, where it can be seen that airway responsiveness to allergen increased continuously from central to distal airways. It should be noted, that the diameter of these small airways was in the range of 100 µm, which corresponds to airway generations 16 and 17, that is, the terminal bronchioles. Thus, the terminal bronchioles are those lung structures that showed the strongest response to allergen. On occasion, we also detected airways that were smaller than 100 µm, and although most of them were principally responsive to allergen these extremely small airways did not react in a predictable fashion (Figure 6). Interestingly, the terminal bronchioles have also been identified in other models and by other methods as the site in the bronchial tree where the bronchoconstriction takes place, that is, in lungs treated with endotoxin (42) or thromboxane (43). Thus, this region of the lung appears to be particularly reactive.
Because the responses to both serotonin and allergen in smaller airways were quicker and stronger than those in larger, more central airways, it could be hypothesized that either the distribution of serotonin receptors varies within the bronchial tree or that mast cell numbers are greater in small airways. It seems also possible that mast cells alongside small airways contain more mediators and thus elicit a faster and stronger response after degranulation. As discussed above, there are at present, however, no data on the serotonin receptor distribution in the airways. With respect to mast cells, Bachelet and coworkers (44) as well as Du and colleagues (41) found fewer mast cells in peripheral than in large membranous airways. Thus the greater sensitivity to allergen does not appear to be related to the numbers of mast cells present.
Alternatively, the greater responsiveness of smaller airways may be explained by structural differences between large bronchi and small bronchioles such as the relatively greater muscular thickness in peripheral airways; airway muscles are most strongly developed in the terminal airways (45). Hence, smooth muscle shortening may result in greater narrowing in small airways than in larger airways (46, 47). Another structural difference between large and small airways may be the number of mucosal folds in the airways. Wiggs and coworkers (48) reasoned that airways with fewer mucosal folds narrow to a greater extent than airways with more folds. Because larger airways may be quite folded, this might account for the decreased contraction after stimulation with the antigen. However, in the only experimental study in this area that is known to us, Mitchell and coworkers (who also observed a greater airway narrowing of small versus large airways) counted mucosal folds in large and small porcine bronchi, but found no correlation with muscle shortening in either group (46). Finally, the increased reactivity of small airways could also be due to other structural features such as a different arrangement and orientation of smooth muscle fibers in large and small airways (49).
The observation that smaller airways responded quicker to allergen is in line with a study of mouse lung explants, where it was not only shown that smaller airways responded quicker to methacholine, but more importantly that the velocity of airway contraction in lung explants from different mouse strains correlated with the degree of bronchial responsiveness in vivo (50). Therefore the smooth muscle shortening velocity may be a major determinant of airway responsiveness. It has even been suggested that the problem in asthma may be that the smooth muscle operates too fast (see [1]).
Potential Relevance to Human Asthma
Thus, compared with larger airways, several different factors may make small airways a preferred target in the early allergic reaction: differences in neural controls, endogenous regulation, structure, and smooth muscle shortening velocity. Regardless of the precise mechanism, if this phenomenon occurs in humans, it has both therapeutic and mechanistic implications. Therapeutically, it would make small airways an important target in the therapy of asthma. Mechanistically, it could explain the increased muscle thickness in small airways from patients with asthma (49, 51), because it is thought that such hypertrophy may be a consequence of overworked airways. Interestingly, we have preliminary evidence obtained in sensitized human lung slices that after antigen challenge greater airway narrowing occurs in smaller airways.
Data based on human tissue that are in line with the present findings were reported by Ellis and coworkers who investigated antigen-induced bronchoconstriction in human airways of different sizes by using isolated central (5- to 12-mm outer diameter) or peripheral airways (0.5 to 2 mm) (9). In that study, tissue was passively sensitized with serum from ragweed-allergic individuals and stimulated after a 16-h incubation period. The authors found that ragweed antigen was 14-fold more potent in peripheral compared with central airways. They also observed a more rapid response to ragweed antigen in peripheral airways. To explain these findings they provided evidence that there is a larger percentage of unoccupied IgE receptors on mast cell in peripheral airways than central airways. However, because it is also known that mast cell numbers decrease along the bronchial tree to the peripheral airways (44, 52), an additional factor for the increased sensitivity of smaller airways probably is the fact that peripheral airways exhibit a greater sensitivity to the released mediators as demonstrated for serotonin in the present study. Further human data that support the notion that smaller airways are more sensitive toward various stimuli are reports showing that in patients with asthma smaller airways are more sensitive to methacholine (53), histamine (8), dry air (6), and bradykinin (7).
A further piece of evidence suggesting that contraction of small airways may be important under physiologic conditions is studies comparing the airway-relaxing effects of bronchodilatory aerosols of different particle sizes. The diameter of aerosol particles determines where in the lung particles are deposited; the smaller the particles the smaller the airways they can reach (54). In such studies it was noted that aerosols made of small particles are more efficient in relaxing airways than those containing larger particles, suggesting that the smaller airways were the major determinant of airway resistance (55).
In summary, we have shown that rat small airways respond in a quicker and stronger fashion to allergen and to serotonin, which appears to be the principal mediator of allergen-induced bronchoconstriction in small and large airways in rats. These findings show that small airways are anything but a silent zone.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Stefan Uhlig, Ph.D., Research Center Borstel, Division Pulmonary Pharmacology, Parkallee 22, Borstel, D-23845 Germany. E-mail: suhlig{at}fz-borstel.de
(Received in original form July 26, 2000 and in revised form January 16, 2001).
Acknowledgments: The authors acknowledge the technical assistance of Cornelia Rodde and Darja Buchholz. They also thank Achim Gronow for the determination of IgE titers in rat serum and Dr. Degenhard Marx and Dr. Waltraut Poppe for rat serum of ova-sensitized rats.
Supported by Deutsche Forschungsgemeinschaft grant DFG Uh 88/3-1.
| |
References |
|---|
|
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES
|
|---|
1. Kraft M. The distal airways: are they important in asthma? Eur Respir J 1999; 14: 1403-1417 [Abstract].
2. Howarth PH, editor. The role of small airways in asthma: a review and key questions. Am J Respir Crit Care Med 1998;157(Suppl):S173-S207.
3. Roche WR. Inflammatory and structural changes in the small airways in bronchial asthma. Am J Respir Crit Care Med 1998;157(Suppl):S191-S194.
4. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 1990; 141: 584-588 [Medline].
5.
Yanai M,
Sekizawa K,
Ohrui T,
Sasaki H,
Takishima T.
Site of airway
obstruction in pulmonary disease: direct measurement of intrabronchial pressure.
J Appl Physiol
1992;
72:
1016-1023
6. Kaminsky DA, Irvin CG, Gurka DA, Feldsien DC, Wagner EM, Liu MC, Wenzel SE. Peripheral airways responsiveness to cool, dry air in normal and asthmatic individuals. Am J Respir Crit Care Med 1995; 152: 1784-1790 [Abstract].
7. Berman AR, Liu MC, Wagner EM, Proud D. Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways. Am J Respir Crit Care Med 1996; 154: 418-423 [Abstract].
8.
Wagner EM,
Bleecker ER,
Permutt S,
Liu MC.
Direct assessment of
small airways reactivity in human subjects.
Am J Respir Crit Care Med
1998;
157:
447-452
9. Ellis JL, Hubbard WC, Meeker S, Undem BJ. Ragweed antigen E and anti-IgE in human central versus peripheral isolated bronchi. Am J Respir Crit Care Med 1994; 150: 717-723 [Abstract].
10. Martin C, Uhlig S, Ullrich V. Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices. Eur Respir J 1996; 9: 2479-2487 [Abstract].
11. Yeh HC, Schum GM. Models of human lung airways and their application to inhaled particle deposition. Bull Math Biol 1980; 42: 461-480 [Medline].
12. Macklem PT. The physiology of small airways. Am J Respir Crit Care Med 1998;157(Suppl):S181-S183.
13. Yeh HC, Schum GM, Duggan MT. Anatomic models of the tracheobronchial and pulmonary regions of the rat. Anat Rec 1979; 195: 483-492 [Medline].
14. Watson N, Bodtke K, Coleman RA, Dent G, Morton BE, Ruhlmann E, Magnussen H, Rabe KF. Role of IgE in hyperresponsiveness induced by passive sensitization of human airways. Am J Respir Crit Care Med 1997; 155: 839-844 [Abstract].
15. Uhlig S, Wollin L. An improved setup for the isolated perfused rat lung. J Pharmacol Toxicol Methods 1994; 31: 85-94 [Medline].
16. Uhlig S. The isolated perfused lung. In: Uhlig S, Taylor AE, editors. Methods in pulmonary research. Basel: Birkhäuser; 1998. p. 29-55.
17. Held HD, Martin C, Uhlig S. Characterization of airway and vascular responses in murine lungs. Br J Pharmacol 1999; 126: 1191-1199 [Medline].
18. Wright SP. Adjusted P-values for simultaneous interference. Biometrics 1992; 48: 1005-1013 .
19.
Uhlig S,
Wollin L,
Wendel A.
Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat.
J
Appl Physiol
1994;
77:
262-269
20. Post MJ, Te Biesebeek JD, Doods HN, Wemer J, Van Rooji HH, Porsius AJ. Functional characterization of the muscarinic receptor in rat lungs. Eur J Pharmacol 1991;202:67-72.
21. Martin C, Held HD, Uhlig S. Differential effects of the mixed ET(A)/ ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release. Naunyn Schmiedebergs Arch Pharmacol 2000; 362: 128-136 [Medline].
22. Kilpatrick LE, Jakabovics E, McCawley LJ, Kane LH, Korchak HM. Cromolyn inhibits assembly of the NADPH oxidase and superoxide anion generation by human neutrophils. J Immunol 1995; 154: 3429-3436 [Abstract].
23. Alton EW, Norris AA. Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma. J Allergy Clin Immunol 1996; 98: S102-S105 [Medline].
24. Almirall JJ, Dolman CS, Eidelman DH. Furosemide-induced bronchodilation in the rat bronchus: evidence of a role for prostaglandins. Lung 1997; 175: 155-163 [Medline].
25. Smit MJ, Timmerman H, Hijzelendoorn JC, Fukui H, Leurs R. Regulation of the human histamine H1 receptor stably expressed in Chinese hamster ovary cells. Br J Pharmacol 1996; 117: 1071-1080 [Medline].
26. Chand N, Pillar J, Nolan K, Diamantis W, Sofia RD. Inhibition of PAF-induced histamine secretion and bronchoconstriction by WEB 2086. Res Commun Chem Pathol Pharmacol 1990; 67: 155-158 [Medline].
27.
Dandurand RJ,
Wang CG,
Phillips NC,
Eidelman DH.
Responsiveness
of individual airways to methacholine in adult rat lung explants.
J
Appl Physiol
1993;
75:
364-372
28. Dandurand RJ, Wang CG, Laberge S, Martin JG, Eidelman DH. In vitro allergic bronchoconstriction in the brown Norway rat. Am J Respir Crit Care Med 1994; 149: 1499-1505 [Abstract].
29. Martin C, Ullrich V, Uhlig S. Effects of the thromboxane receptor agonist U46619 and endothelin-1 on large and small airways. Eur Respir J 2000; 16: 316-323 [Abstract].
30. Church MK. Response of rat lung to humoral mediators of anaphylaxis and its modification by drugs and sensitization. Br J Pharmacol 1975; 55: 423-430 [Medline].
31. Purcell WM, Cohen DL, Hanahoe TH. Comparison of histamine and 5-hydroxytryptamine content and secretion in rat mast cells isolated from different anatomical locations. Int Arch Allergy Appl Immunol 1989; 90: 382-386 [Medline].
32. Martin JG, Xu LJ, Toh MY, Olivenstein R, Powell WS. Leukotrienes in bile during the early and the late airway responses after allergen challenge of sensitized rats. Am Rev Respir Dis 1993; 147: 104-110 [Medline].
33. Sapienza S, Eidelman DH, Renzi PM, Martin JG. Role of leukotriene D4 in the early and late pulmonary responses of rats to allergen challenge. Am Rev Respir Dis 1990; 142: 353-358 [Medline].
34. Nagase T, Fukuchi Y, Dallaire MJ, Martin JG, Ludwig MS. In vitro airway and tissue response to antigen in sensitized rats: role of serotonin and leukotriene D4. Am J Respir Crit Care Med 1995; 152: 81-86 [Abstract].
35. Das DK, Steinberg H. Serotonin receptors in rat lung. Respiration 1986; 49: 27-36 [Medline].
36.
Carstairs JR,
Barnes PJ.
Visualization of vasoactive intestinal peptide receptors in human and guinea pig lung.
J Pharmacol Exp Ther
1986;
239:
249-255
37.
Palmer JB,
Cuss FM,
Barnes PJ.
VIP and PHM and their role in nonadrenergic inhibitory responses in isolated human airways.
J Appl Physiol
1986;
61:
1322-1328
38. Frossard N, Barnes J. Effect of tachykinins in small human airways. Neuropeptides 1991; 19: 157-161 [Medline].
39. Carstairs JR, Barnes PJ. Autoradiographic mapping of substance P receptors in lung. Eur J Pharmacol 1986; 127: 295-296 [Medline].
40.
Bradley SL,
Russell JA.
Distribution of histamine receptors in isolated
canine airways.
J Appl Physiol
1983;
54:
693-700
41. Du T, Sapienza S, Eidelman DH, Wang NS, Martin JG. Morphometry of the airways during late responses to antigen challenge in the rat. Am Rev Respir Dis 1991; 143: 132-137 [Medline].
42. Uhlig S, Brasch F, Wollin L, Fehrenbach H, Richter J, Wendel A. Functional and fine structural changes in isolated rat lungs challenged with endotoxin ex vivo and in vitro. Am J Pathol 1995; 146: 1235-1247 [Abstract].
43. Uhlig S, Nusing R, von Bethmann A, Featherstone RL, Klein T, Brasch F, Muller KM, Ullrich V, Wendel A. Cyclooxygenase-2-dependent bronchoconstriction in perfused rat lungs exposed to endotoxin. Mol Med 1996; 2: 373-383 [Medline].
44. Bachelet CM, Bernaudin JF, Fleury-Feith J. Distribution and histochemical characterization of pulmonary mast cells in the rat and guinea pig. Int Arch Allergy Appl Immunol 1988; 87: 225-229 [Medline].
45. Ebina M, Yaegashi H, Chiba R, Takahashi T, Motomiya M, Tanemura M. Hyperreactive site in the airway tree of asthmatic patients revealed by thickening of bronchial muscles: a morphometric study. Am Rev Respir Dis 1990; 141: 1327-1332 [Medline].
46. Mitchell HW, Cvetkovski R, Sparrow MP, Gray PR, McFawn PK. Concurrent measurement of smooth muscle shortening, lumen narrowing and flow to acetylcholine in large and small porcine bronchi. Eur Respir J 1998; 12: 1053-1061 [Abstract].
47. Moreno RH, Hogg JC, Pare PD. Mechanics of airway narrowing. Am Rev Respir Dis 1986; 133: 1171-1180 [Medline].
48.
Wiggs BR,
Hrousis CA,
Drazen JM,
Kamm RD.
On the mechanism of
mucosal folding in normal and asthmatic airways.
J Appl Physiol
1997;
83:
1814-1821
49.
Bates JH,
Martin JG.
A theoretical study of the effect of airway smooth
muscle orientation on bronchoconstriction.
J Appl Physiol
1990;
69:
995-1001
50.
Duguet A,
Biyah K,
Minshall E,
Gomes R,
Wang CG,
Taoudi-Benchekroun M,
Bates JH,
Eidelman DH.
Bronchial responsiveness among
inbred mouse strains: role of airway smooth-muscle shortening velocity.
Am J Respir Crit Care Med
2000;
161:
839-848
51. Saetta M, Di Stefano A, Rosina C, Thiene G, Fabbri LM. Quantitative structural analysis of peripheral airways and arteries in sudden fatal asthma. Am Rev Respir Dis 1991; 143: 138-143 [Medline].
52. Nagase T, Moretto A, Dallaire MJ, Eidelman DH, Martin JG, Ludwig MS. Airway and tissue responses to antigen challenge in sensitized brown Norway rats. Am J Respir Crit Care Med 1994; 150: 218-226 [Abstract].
53. Sekizawa K, Sasaki H, Shimizu Y, Takishima T. Dose-response effects of methacholine in normal and in asthmatic subjects: relationship between the site of airway response and overall airway hyperresponsiveness. Am Rev Respir Dis 1986; 133: 593-599 [Medline].
54. Murray JF, Nadler AJ. Defense mechanisms and immunology. In: Textbook of Respiratory Medicine. Philadelphia: W.B. Saunders; 1994. p. 346-350.
55. Rees PJ, Clark TJ, Moren F. The importance of particle size in response to inhaled bronchodilators. Eur J Respir Dis Suppl 1982; 119: 73-78 [Medline].
This article has been cited by other articles:
 |
|
 |
|
  Y. Bai, M. Zhang, and M. J. Sanderson Contractility and Ca2+ Signaling of Smooth Muscle Cells in Different Generations of Mouse Airways Am. J. Respir. Cell Mol. Biol., January 1, 2007; 36(1): 122 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Ressmeyer, A. K. Larsson, E. Vollmer, S. E. Dahlen, S. Uhlig, and C. Martin Characterisation of guinea pig precision-cut lung slices: comparison with human tissues Eur. Respir. J., September 1, 2006; 28(3): 603 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bayat, L. Porra, H. Suhonen, C. Nemoz, P. Suortti, and A. R. A. Sovijarvi Differences in the time course of proximal and distal airway response to inhaled histamine studied by synchrotron radiation CT J Appl Physiol, June 1, 2006; 100(6): 1964 - 1973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Perez and M. J. Sanderson The Frequency of Calcium Oscillations Induced by 5-HT, ACH, and KCl Determine the Contraction of Smooth Muscle Cells of Intrapulmonary Bronchioles J. Gen. Physiol., May 31, 2005; 125(6): 535 - 553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Struckmann, S. Schwering, S. Wiegand, A. Gschnell, M. Yamada, W. Kummer, J. Wess, and R. V. Haberberger Role of Muscarinic Receptor Subtypes in the Constriction of Peripheral Airways: Studies on Receptor-Deficient Mice Mol. Pharmacol., December 1, 2003; 64(6): 1444 - 1451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Wohlsen, C. Martin, E. Vollmer, D. Branscheid, H. Magnussen, W-M. Becker, U. Lepp, and S. Uhlig The early allergic response in small airways of human precision-cut lung slices Eur. Respir. J., June 1, 2003; 21(6): 1024 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S. Kott, K. E. Pinkerton, J. M. Bric, C. G. Plopper, K. P. Avadhanam, and J. P. Joad Methacholine responsiveness of proximal and distal airways of monkeys and rats using videomicrometry J Appl Physiol, March 1, 2002; 92(3): 989 - 996. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. TOBIN Asthma, Airway Biology, and Nasal Disorders in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 598 - 618. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK |